高盛主要观点如下： 资金流向上 —— 高盛的交易平台买入呈现 1.2 倍净卖出状态。消费和科技板块是平台最活跃的主题(双 向交易并存，但消费股更适合卖出而科技股更宜买入)。消费板块呈现双向流动，餐饮类股遭遇部分抛 售，而普拉达等零售股则买卖交投活跃。科技板块中，持续在硬科技领域获得买单，但对腾讯音乐等冲 高个股转为卖出。网易也获得较大力度买入。医疗保健 / 制药板块更受青睐 —— 翰森制药虽呈双向交 易但买方更占优势。 香港股市创下自五月初以来的最佳单日表现。 从行业板块来看，医疗保健、科技和消费板块领涨 —— 在中国政府宣布对符合条件的个人消费贷款实 施贴息计划后，国内零售商与消费医疗企业的股价应声上扬。医疗板块中，信达生物(+9%)、药明康德 (+6.2%)、翰森制药(+5.4%)涨幅居前。科技板块以腾讯音乐(+15.6%)表现最为亮眼，其财报大幅超出预 期，多家投行同步上调目标价。其他涨幅显著的个股包括阿里巴巴(+6.1%)、哔哩哔哩(+7.4%)，华虹半 导体(+5.9%)等芯片股亦表现强势。能源与电信板块表现滞后，虽维持涨势但明显跑输大盘，部分资金 正轮动至成长股。 智通财经APP获悉，高盛发布研报 ...

Key Points - Xiaomi Group-W (01810), Crystal International Holdings (02228), and BYD Electronic (00285) ranked top in net inflow of southbound funds, with net inflows of 562 million, 227 million, and 213 million respectively [1][2] - Xpeng Motors-W (09868), Innovent Biologics (01801), and Ganfeng Lithium (01772) had the highest net outflows, with net outflows of -663 million, -535 million, and -410 million respectively [1][2] - In terms of net inflow ratio, Haitian Flavoring and Food (03288), Jiangsu Nanjing Highway (00177), and Swire Properties B (00087) led the market with ratios of 55.51%, 49.37%, and 46.46% respectively [1][2] - The highest net outflow ratios were recorded by Reshape Energy (02570), Southbound Hang Seng Index ETF (03037), and First Pacific Company (00142) with ratios of -90.77%, -68.70%, and -60.36% respectively [1][3] Net Inflow Rankings - Xiaomi Group-W (01810) had a net inflow of 562 million, representing 8.75% of its closing price of 50.800, which decreased by 0.88% [2] - Crystal International Holdings (02228) saw a net inflow of 227 million, with a net inflow ratio of 11.34% and a closing price of 7.450, which increased by 4.78% [2] - BYD Electronic (00285) recorded a net inflow of 213 million, with a net inflow ratio of 13.41% and a closing price of 38.680, which increased by 6.15% [2] Net Outflow Rankings - Xpeng Motors-W (09868) experienced the largest net outflow of -663 million, with a net outflow ratio of -20.13% and a closing price of 83.600, which increased by 5.36% [2] - Innovent Biologics (01801) had a net outflow of -535 million, with a net outflow ratio of -19.67% and a closing price of 89.950, which decreased by 1.42% [2] - Ganfeng Lithium (01772) recorded a net outflow of -410 million, with a net outflow ratio of -19.45% and a closing price of 34.000, which increased by 20.91% [2] Net Inflow Ratio Rankings - Haitian Flavoring and Food (03288) had a net inflow ratio of 55.51%, with a net inflow of 21.1399 million and a closing price of 33.560, which decreased by 0.47% [3] - Jiangsu Nanjing Highway (00177) recorded a net inflow ratio of 49.37%, with a net inflow of 14.6726 million and a closing price of 9.980, which decreased by 0.40% [3] - Swire Properties B (00087) had a net inflow ratio of 46.46%, with a net inflow of 4.0945 million and a closing price of 12.160, which decreased by 0.57% [3]

Group 1 - The core point of the news is that despite a significant rise in the Hong Kong stock market, southbound funds recorded a net sell-off of 8.277 billion HKD, indicating a potential shift in investor sentiment [1] - Southbound funds have consistently net bought Xiaomi for five consecutive days, totaling 3.31711 billion HKD, suggesting strong investor interest in the company [1] - The net buying and selling activities highlight specific stocks, with notable net purchases in companies like Innovent Biologics (709 million HKD) and Li Auto (366 million HKD), while significant net sell-offs were observed in the Tracker Fund of Hong Kong (6.85 billion HKD) and Tencent Holdings (2.5 billion HKD) [1][3] Group 2 - The data shows that Tencent Holdings experienced a 4.7% decline with a net sell-off of 1.81 billion HKD, while Alibaba saw a 6.1% drop with a net sell-off of 5.25 billion HKD [3] - The Tracker Fund of Hong Kong had a significant net sell-off of 4.6 billion HKD, indicating a bearish sentiment towards this fund [3] - In contrast, companies like Innovent Biologics and Li Auto saw positive movements, with net purchases of 709 million HKD and 1.12 billion HKD respectively, reflecting a more favorable outlook from investors [3]

Core Insights - Alibaba Health and Innovent Biologics have signed a strategic cooperation agreement to enhance post-disease management, supply chain, and digital marketing services for consumers [1][2] Group 1: Strategic Cooperation - The collaboration will focus on developing a post-disease management system that includes medication guidance, lifestyle consultation, and supportive services for patients [2] - Customized supply chain solutions will be provided by Alibaba Health to ensure compliance and safe delivery of temperature-sensitive medications [2] - Joint efforts will be made in digital marketing to promote scientific weight loss knowledge and facilitate online appointment services [2] Group 2: Company Profiles - Alibaba Health is a flagship platform of Alibaba Group that integrates online and offline resources in the pharmaceutical and health industry, offering a one-stop medical solution [1] - Innovent Biologics is a leading biopharmaceutical company in China with 16 innovative drugs on the market, including a recently approved weight loss drug [1][2] - The partnership aims to leverage the strengths of both companies in medical innovation and healthcare accessibility [2][3] Group 3: Future Aspirations - Alibaba Health aims to utilize its digital operations and supply chain advantages to efficiently deliver quality medications and services to patients [3] - There is an expectation to explore further collaborations in areas such as oncology and ophthalmology to provide sustainable high-quality healthcare services [3]

FIT HON TENG为近一个月首次上榜，当日港股通成交额为9.22亿港元，成交净买入2.35亿港元，该股 当日收盘上涨11.78%。（数据宝） 8月13日港股通成交活跃股榜单 | 证券 | 证券简称 | 成交金额（亿 | 净买入金额（亿 | 近一个月上榜 | 最新收盘价 | 日涨跌幅 | | --- | --- | --- | --- | --- | --- | --- | | 代码 | | 港元） | 港元） | 次数 | （港元） | （%） | | 00700 | 腾讯控股 | 90.93 | -2.50 | 23 | 586.000 | 4.74 | | 00981 | 中芯国际 | 40.42 | 0.12 | 23 | 52.050 | 1.76 | | 01810 | 小米集团 W | 43.17 | 1.76 | 23 | 53.250 | 3.00 | | 09988 | 阿里巴巴 W | 85.97 | -2.43 | 23 | 123.700 | 6.09 | | 03690 | 美团-W | 40.05 | -1.88 | 20 | 124.300 | 4.10 | | 01788 ...

| 代码 | 简称 | 成交金额（万港元） | 成交净买入（万港元） | 今日涨跌幅（%） | | --- | --- | --- | --- | --- | | 01801 | 信达生物 | 126973.63 | 70920.60 | 8.82 | | 02015 | 理想汽车-W | 251365.27 | 36684.97 | 3.30 | | 06088 | FITHONTENG | 92228.55 | 23494.79 | 11.78 | | 01810 | 小米集团-W | 431651.31 | 17588.47 | 3.00 | | 01788 | 国泰君安国际 | 139526.24 | 5618.78 | -1.47 | | 01024 | 快手-W | 124943.81 | 1929.62 | 4.68 | | 00981 | 中芯国际 | 404165.75 | 1244.92 | 1.76 | | 02228 | 晶泰控股 | 164926.30 | -5391.42 | 9.80 | | 03690 | 美团-W | 400524.52 | -18823.57 | 4.10 ...

Group 1 - The core viewpoint of the news is the performance and holdings of the Zhongyin Innovation Medical Mixed Fund C, which has shown significant growth in recent months and has a strong portfolio in the healthcare sector [1][3]. - As of August 13, 2025, the latest net value of Zhongyin Innovation Medical Mixed Fund C is 2.1969 yuan, reflecting a growth of 3.87% [1]. - The fund has achieved a return of 15.09% over the past month, ranking 1008 out of 4699 in its category [1]. - Over the last six months, the fund's return is 86.76%, ranking 26 out of 4543 [1]. - Year-to-date, the fund has returned 85.33%, ranking 30 out of 4501 [1]. - The top ten stock holdings of the fund account for a total of 62.83%, with significant positions in companies such as Innovent Biologics (8.33%), Kelun-Biotech (8.15%), and Hengrui Medicine (8.08%) [1]. Group 2 - The Zhongyin Innovation Medical Mixed Fund C was established on October 30, 2020, and as of June 30, 2025, it has a total scale of 2.686 billion yuan [1]. - The fund manager, Zheng Ning, has a background in asset management and has held various positions in the investment industry, including roles at Taikang Asset Management and Zhonggeng Fund Management [2]. - Zheng Ning has been managing the Zhongyin Innovation Medical Mixed Fund C since July 1, 2022, and has also taken on management roles for other funds within the healthcare sector [2].

深港通（南向）十大活跃成交公司 2025年8月13日当天，腾讯控股(00700)、阿里巴巴-W(09988)、盈富基金(02800)位居沪港通（南向）成 交额前3位，成交额分别为51.84 亿元、49.20 亿元、46.54 亿元；腾讯控股(00700)、阿里巴巴- W(09988)、盈富基金(02800) 位居深港通（南向）成交额前3位，成交额分别为39.10 亿元、36.78 亿 元、22.08 亿元。 沪港通（南向）十大活跃成交公司 | 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 腾讯控股(00700) | 51.84 亿元 | -1.81 亿元 | | 阿里巴巴-W(09988) | 49.20 亿元 | -5.25 亿元 | | 盈富基金(02800) | 46.54 亿元 | -46.46 亿元 | | 中芯国际(00981) | 27.01 亿元 | +7850.05 万元 | | 小米集团-W(01810) | 27.00 亿元 | -7428.30 万元 | | 恒生中国企业(02828) | 25.33 亿元 | -23.11 亿元 | | 美团- ...

Core Insights - Southbound capital recorded a total transaction of 153.78 billion HKD on August 13, with a net outflow of approximately 8.28 billion HKD [1] - The Shanghai-Hong Kong Stock Connect experienced a net outflow of about 8.46 billion HKD, while the Shenzhen-Hong Kong Stock Connect saw a net inflow of around 0.18 billion HKD [1] Group 1: Significant Net Purchases - Xinda Biologics (01801.HK) had a net purchase of 709 million HKD and saw a price increase of 8.82% [1] - Li Auto-W (02015.HK) recorded a net purchase of 367 million HKD, with a price increase of 3.30% [1] - FIT HON TENG (06088.HK) experienced a net purchase of 235 million HKD and a price increase of 11.78% [1] - Xiaomi Group-W (01810.HK) had a net purchase of 176 million HKD, with a price increase of 3.00% [2] - Guotai Junan International (01788.HK) saw a net purchase of 56.18 million HKD despite a price drop of 1.47% [3] - Kuaishou-W (01024.HK) had a net purchase of 19.30 million HKD and a price increase of 4.68% [4] Group 2: Significant Net Sales - The Yingfu Fund (02800.HK) faced a net sale of approximately 6850.25 million HKD, with a price increase of 2.35% [5] - The Hang Seng China Enterprises Index (02828.HK) had a net sale of about 2311.16 million HKD, with a price increase of 2.76% [6] - Tencent Holdings (00700.HK) recorded a net sale of approximately 250.29 million HKD, with a price increase of 4.74% [7] - Alibaba Group-W (09988.HK) experienced a net sale of about 242.99 million HKD, with a price increase of 6.09% [8]

| 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 腾讯控股 | 25.02亿 | 26.82 乙 | 51.84 乙 | | HK 00700 | | | -1.81 Z | | 阿里巴巴-W | 21.98 乙 | 27.22 乙 | 49.20亿 | | HK 09988 | | | -5.25 亿 | | 盈富基金 | 379.94万 | 46.50 乙 | 46.54亿 | | HK 02800 | | | -46.46 Z | | 中芯国际 | 13.90亿 | 13.11亿 | 27.01亿 | | HK 00981 | | | +7850.05万 | | 小米集团-W | 13.13 乙 | 13.87亿 | 27.00亿 | | HK 01810 | | | -7428.30万 | | 恒牛中国 ... | 1.11亿 | 24.221Z | 25.33亿 | | HK 02828 | | | -23.11 乙 | | 美团-W | 10.59 乙 | 12.13亿 | 22.72亿 | | HK 036 ...